| Term 
 
        | Cyclosporine Use
 mechanism
 Adv. Effects
 Contra
 Interactions
 Metabolism
 |  | Definition 
 
        | Prevent Trans rejection/GVHD Autoimmune/Inflammatory disorders
 Bind to cyclophilin
 Inhibit calcineurin
 Stop NF-AT from entering nucleus
 Stop cytokine production
 Nephrotoxicity (does limiting - via renal vasoconstriciton)
 Neurotoxicity (tremor)
 Hypertension
 Hyperlipidemia
 Hyperuricemia
 Hyperkalemia
 Hirsutism
 Gingival hyperplasia
 Breastfeeding
 Hypersensitivity
 Statins via CYP3A4
 CYP3A4/PGP inhibitor
 |  | 
        |  | 
        
        | Term 
 
        | Tacrolimus Use
 mechanism
 Adv. Effects
 Contra
 Metabolism
 |  | Definition 
 
        | Prevent & Treat Trans. rejection/GVHD Bind to FKBP
 Inhibit calcineurin
 Stop NF-AT from entering nucleus
 Stop cytokine production
 Nephrotoxicity (dose limit - via renal vasoconstriciton)
 Neurotoxicity (tremor +)
 Hypertension
 Hyperkalemia
 Hyperglycemia
 Liver enzymes up
 GI upset
 Breastfeeding
 Hypersensitivity
 CYP3A4/PGP metabolism
 High protein binding
 |  | 
        |  | 
        
        | Term 
 
        | Sirolimus Use
 mechanism
 Adv. Effects
 Contra
 Metabolism
 |  | Definition 
 
        | Prevent Trans Rejection Bind FKBP
 inhibit mTOR in IL-2 pathway
 Stop G1->S phase
 Stops proliferation
 Hypertension
 Hyperlipidemia
 Lymphocele risk up (renal transplant)
 Poor wound healing
 Clotting disorders
 Anemia/neutropenia
 No contra
 Synergism w/ cyclosporin
 CsA - up [sirolimus]
 increase nephrotoxicity
 CYP3A4/PGP
 |  | 
        |  | 
        
        | Term 
 
        | Mycophenolate Class
 Use
 mechanism
 Adv. Effects
 Interactions
 Metabolism
 |  | Definition 
 
        | Anti-metabolite Prevent/Treat Trans rejection/GVHD
 Autoimmune diseases
 noncompetitive IMPDH inhib.
 stop de novo purine synthesis
 Stop DNA/RNA synthesis
 GI upset
 Renal tubular necrosis 10-20%
 Myelosuppression
 CsA inhibits secretion into bile
 Glucuronide conjug.
 Excreted via kindey and bile (enterohepatic recycling)
 High protein bound
 No Cyp/PGP
 |  | 
        |  | 
        
        | Term 
 
        | Methotrexate Class
 Use
 mechanism
 Adv. Effects
 Contra
 Interactions
 Metabolism
 |  | Definition 
 
        | Anti-metabolite Prevent GVHD (rare
 cancer chemo
 Inflammatory/autoimmune disease
 RA
 Psoriasis
 Folate antimetabolite
 AICAR build up
 Adenosine up
 Inhibit NF-kB
 Inhibit purine.pyrimadine synthesis
 Hepatotoxicity
 GI
 Hyperhomocysteinuria
 Myelosuppression
 Renal toxicity (precip in tubules)
 Teratogenesis
 Pregnancy/Breastfeeding
 Myelosuppression/AIDS
 Salicylates/NASIDs compete prot binding
 Penicillin inhib MTX elimination
 Folate supplement - stop adverse effects.
 Polyglutamated in cell - retention
 High protein binding
 No CYP/PGP
 |  | 
        |  | 
        
        | Term 
 
        | Azathioprine Class
 Use
 mechanism
 Adv. Effects
 Contra
 Interactions
 Metabolism
 |  | Definition 
 
        | Anti-metabolite Prevent Trans rejection
 Autoimm/Inflamm diseases
 ->6-MP->6-TGN
 6TGN stops DNA synthesis (dideoxy)
 6MP inhibit de novo purine synthesis
 GI upset
 Myelosuppression
 Hepatotoxicity
 Pregnancy/Breastfeeding
 Xanthine oxidase destroys 6MP
 Allopurinol (gout) inhibits xan oxid.
 No CYP/PGP (Xan oxidase)
 |  | 
        |  | 
        
        | Term 
 
        | Antithymocyte Globulin Class
 Use
 mechanism
 Adv. Effects
 Contra
 |  | Definition 
 
        | Antibody Prevent/Treat Trans rejec/GVHD
 Anti-T-cell Ab
 Opsonize T cells
 Serum sickness
 Thrombocytopenia/neutropenia (cross rxn)
 Hypersensitivity to rabbit/horse
 |  | 
        |  | 
        
        | Term 
 
        | Muromonab Class
 Use
 mechanism
 Adv. Effects
 Contra
 |  | Definition 
 
        | Antibody Treat Trans rejection
 Anti-CD3
 Internalization of TCR
 Cytokine release syndrome
 Severe pulmonary edema
 Hypervolemia
 Heart Failure
 Hypersensitivity to mouse
 |  | 
        |  | 
        
        | Term 
 
        | Daclizumab Class
 Use
 mechanism
 Adv. Effects
 Contra
 |  | Definition 
 
        | Antibody Prevent Trans rejection
 Anti IL2R AB
 inhibit IL-2 and activ. of T cells
 Serum sickenss
 use in combo - no added ADR
 Hypersensitivity
 |  | 
        |  | 
        
        | Term 
 
        | Basiliximab Class
 Use
 mechanism
 Adv. Effects
 Contra
 |  | Definition 
 
        | Antibody Prevent Trans rejection
 Anti IL2R AB
 inhibit IL-2 and activ. of T cells
 Serum sickenss
 use in combo - no added ADR
 Hypersensitivity
 |  | 
        |  | 
        
        | Term 
 
        | Cyclophosphamide Use
 Mechanism
 |  | Definition 
 
        | Lupus nephritis Prevent/treat trans rejection
 Cancer chemo
 Alkylating agent - DNA cross links
 |  | 
        |  | 
        
        | Term 
 
        | Glucocorticoids Use
 Mechanism
 Adverse Effects
 |  | Definition 
 
        | Prevent/Treat Trans rejection Autoimm/Inflamm dis
 RA - for flare ups (last resort)
 SLE
 Bind to receptor
 Reverse NF-kB actions
 Deacetylation of histones
 Turn off HAT/NF-kB
 Bind ot DNa promoters
 CNS stimulation
 Appetite stimulation OR NV
 Adrenal crisis
 Infection risk up
 Osteoporosis
 Diabetes
 Glaucoma
 |  | 
        |  |